Several board members commented on the fact that at present, only $300 million of the anticipated $1,000 million cost of Round 5 has been promised. This led to a resolution saying “The Board notes with concern the current shortfall regarding funds available for Round 5. The Board calls upon participants of the Replenishment Conference, and all other potential donors, to…
Global Fund Inspector General
As a result of pressure from the United States, the Board agreed to appoint an Inspector General. The role of the office of the inspector general will be to assess whether the Global Fund and its grant recipients are using the money in the ways intended. Inspections, both announced and unannounced, will be conducted of the Global Fund, PRs, Sub-Recipients,…
Quality Assurance of Limited Source Pharmaceutical Products
At its October 2002 meeting, the board decided that if a medicinal product is to be eligible for purchase using Global Fund grants, it must meet various requirements. One of these is that if it is a “single- or limited-source product,” it must (a) have been found to be acceptable by the WHO-initiated UN Pilot Procurement Quality and Sourcing Project,…
Committee Restructuring
Bernard Rivers
Phase 2 Grants
Bernard Rivers
Funding of CCM Secretariats
Bernard Rivers
CCM Authority over PRs
Bernard Rivers
New Chair and Vice-Chair
Bernard Rivers
Global Fund Board Completes Tenth Board Meeting
This issue of GFO is devoted almost entirely to decisions made at the Global Fund board meeting that took place in Geneva on April 21-22. The Fund holds three board meetings per year. This was the tenth such meeting. GFO was present, with observer status. The meeting continued the constructive and cooperative tone that has been the pattern for some…